The UK is witnessing a significant surge in interest surrounding entheogenic substances. Beyond the familiar use of psilocybin and LSD, researchers and adventurers are increasingly exploring less-charted frontiers, particularly copyright and the relatively new cannabinoid, CBG compound. The evolv